These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 11344219

  • 1. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
    Chatzistamou I, Schally AV, Varga JL, Groot K, Armatis P, Busto R, Halmos G.
    J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL.
    Prostate; 2002 Aug 01; 52(3):173-82. PubMed ID: 12111694
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
    Plonowski A, Schally AV, Varga JL, Rekasi Z, Hebert F, Halmos G, Groot K.
    Prostate; 2000 Jul 01; 44(2):172-80. PubMed ID: 10881027
    [Abstract] [Full Text] [Related]

  • 4. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
    Szereday Z, Schally AV, Varga JL, Kanashiro CA, Hebert F, Armatis P, Groot K, Szepeshazi K, Halmos G, Busto R.
    Cancer Res; 2003 Nov 15; 63(22):7913-9. PubMed ID: 14633721
    [Abstract] [Full Text] [Related]

  • 5. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.
    Kahán Z, Varga JL, Schally AV, Rékási Z, Armatis P, Chatzistamou L, Czömpöly T, Halmos G.
    Breast Cancer Res Treat; 2000 Mar 15; 60(1):71-9. PubMed ID: 10845811
    [Abstract] [Full Text] [Related]

  • 6. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M.
    Prostate; 2005 Aug 01; 64(3):303-15. PubMed ID: 15754342
    [Abstract] [Full Text] [Related]

  • 7. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.
    Szepeshazi K, Schally AV, Groot K, Armatis P, Halmos G, Herbert F, Szende B, Varga JL, Zarandi M.
    Br J Cancer; 2000 May 01; 82(10):1724-31. PubMed ID: 10817510
    [Abstract] [Full Text] [Related]

  • 8. Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.
    Kiaris H, Schally AV, Varga JL.
    Neoplasia; 2000 May 01; 2(3):242-50. PubMed ID: 10935510
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
    Chatzistamou I, Schally AV, Sun B, Armatis P, Szepeshazi K.
    Br J Cancer; 2000 Oct 01; 83(7):906-13. PubMed ID: 10970693
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro.
    Csernus VJ, Schally AV, Kiaris H, Armatis P.
    Proc Natl Acad Sci U S A; 1999 Mar 16; 96(6):3098-103. PubMed ID: 10077643
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R, Schally AV, Plonowski A, Varga JL, Groot K, Krupa M, Armatis P.
    Cancer; 2002 Oct 15; 95(8):1735-45. PubMed ID: 12365022
    [Abstract] [Full Text] [Related]

  • 12. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E, Schally AV, Buchholz S, Rick FG, Halmos G, Mile M, Groot K, Hohla F, Zarandi M, Varga JL.
    Prostate; 2008 Dec 01; 68(16):1763-72. PubMed ID: 18729085
    [Abstract] [Full Text] [Related]

  • 13. Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma.
    Kiaris H, Schally AV, Varga JL.
    Cancer Lett; 2000 Dec 20; 161(2):149-55. PubMed ID: 11090963
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.
    Kanashiro CA, Schally AV, Groot K, Armatis P, Bernardino AL, Varga JL.
    Proc Natl Acad Sci U S A; 2003 Dec 23; 100(26):15836-41. PubMed ID: 14660794
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M, Kineman RD, Schally AV, Zarandi M, Groot K, Frohman LA.
    Endocrinology; 1997 Nov 23; 138(11):4536-42. PubMed ID: 9348175
    [Abstract] [Full Text] [Related]

  • 18. Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth.
    Szepeshazi K, Schally AV, Armatis P, Groot K, Hebert F, Feil A, Varga JL, Halmos G.
    Endocrinology; 2001 Oct 23; 142(10):4371-8. PubMed ID: 11564700
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Chatzistamou I, Schally AV, Varga JL, Groot K, Armatis P, Bajo AM.
    J Cancer Res Clin Oncol; 2001 Nov 23; 127(11):645-52. PubMed ID: 11710593
    [Abstract] [Full Text] [Related]

  • 20. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M, Zarándi M, Halmos G, Groot K, Schally AV.
    Endocrinology; 1996 Dec 23; 137(12):5364-9. PubMed ID: 8940358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.